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A B S T R A C T   
Toxicity and poor adherence to treatment that favors the generation of resistance in the Leishmania parasites 
highlight the need to develop better alternatives. Here, we evaluated the in vitro effectiveness of hydrazone 
derived from chromanes 2-(2,3-dihydro-4H-1-benzothiopyran-4-ylidene) hydrazide (TC1) and 2-(2,3-dihydro- 
4H-1-benzopyran-4-ylidene) hydrazide (TC2) and the mixture of triterpene saponin hederagenin-3-O-(3,4-O- 
diacetyl-ß-D-xylopyranosyl-(1�a3)-a-L- rhamnopyranosyl-(1�a2)-a-L-arabinofuranoside, hederagenin-3-O-(3,4-O- 
diacetyl-a-L- arabinopyranosyl-(1�a3)-a-L-rhamnopyranosyl-(1�a2)-a-L-arabinofuranoside and, hederagenin-3-O- 
(4-O-acetyl-ß-D-xylopyranosyl-(1�a3)-a-L-rhamnopyranosyl-(1�a2)-a-L-arabinofuranoside from Sapindus saponaria 
(SS) on L. braziliensis and L. pifanoi. Mixtures of TC1 or TC2 with saponin were formulated for topical application 
and the therapeutic effectiveness was evaluated in the model for cutaneous leishmaniasis (CL) in golden hamster. 
The mode of action of these compounds was tested on various parasite processes and ultrastructural parasite 
modifications. TC1, TC2 and SS showed moderate cytotoxicity when tested independently but toxicity was 
improved when tested in combination. The compounds were more active against intracellular Leishmania 
amastigotes. In vivo studies showed that combinations of TC1 or TC2 with SS in 1:1 ratio (w/w) cured 100% of 
hamsters with no signs associated with toxicity. The compounds did cause changes in the mitochondrial activity 
of the parasite with a decrease in ATP levels and depolarization of membrane potential and overproduction of 
reactive oxygen species; nevertheless, these effects were not related to alterations in membrane permeability. 
The phagolysosome ultrastructure was also affected impacting the survival of Leishmania but the function of the 
lysosome nor the pH inside the phagolysosome did not change. Lastly, there was a protease inhibition which was 
directly related to the decrease in the ability of Leishmania to infect and multiply inside the macrophage. The 
results suggest that the combination of TC1 and TC2 with SS in a 1:1 ratio is capable of curing CL in hamsters. 
This effect may be due to the ability of these compounds to affect parasite survival and the ability to infect new 
cells.   
1. Introduction 
Leishmaniasis is an infectious disease caused by parasites of the 
genus Leishmania. It is manifested by nodules, plaques, or ulcers in the 
skin; also by mucous membranes of the oral-nasopharyngeal region; or a 
typical clinical presentation consists of lesions in bone marrow, liver, 
spleen, and pancreas. These signs are clinically defined as cutaneous 
leishmaniasis (CL), mucosal leishmaniasis (ML), or visceral leishmani-
asis (VL), respectively (WHO, 2010). 
Leishmaniasis is endemic in 98 countries in the tropical and 
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subtropical regions, with 350 million people at risk of getting the 
infection and 2 million people infected each year. No vaccine prevents 
infection, and therapeutic options for the treatment of the disease are 
scarce. The treatments require high doses of the medications, favoring 
toxicity with the consequent low adherence to the treatment and the 
appearance of resistance in the strains of circulating parasites (WHO, 
2010). Because therapeutic options are insufficient, it is necessary to 
work decisively in the search for new and better therapeutic options that 
are not only more effective but also safer. 
Hydrazones derived from thiochromanone (Vargas et al., 2018) and 
benzophenones (Al-Kahraman et al., 2012) have shown antileishmanial 
potential against L. panamensis and L. major, respectively. The 7-chlor-
o-4-quinolinyl hydrazones have also shown activity against Leishmania 
species from the new and the old world (Coimbra et al., 2013). On the 
other hand, some saponins such as oleanolic acid and triterpene saponin 
PX6518 have shown promising results in vitro and in vivo for VL and CL 
(Melo et al., 2016; Inocencio da Luz et al., 2011), and the pure saponins 
of Sapindus saponaria resin hederagenin-3-O - (3,4-O-diacetyl -ß-D- 
xylopyranosyl - (1�a3)-a-L- rhamnopyranosyl-(1�a2)-a-L- arabinofurano-
side, hederagenin-3-O-(3,4-O- diacetyl -a-L- arabinopyranosyl 
-(1�a3)-a-L- rhamnopyranosyl -(1�a2)-a-L- arabinofuranoside and 
hederagenin-3-O-(4-O-acetyl-ß-D- xylopyranosyl -(1�a3)-a-L- rhamno-
pyranosyl -(1�a2)-a-L- arabinofuranoside (SS) (Fig. 1) that demonstrated 
in vitro antileishmanial activity to L. panamensis, L. amazonensis and, but 
also in vivo activity to L. panamensis (Correa et al., 2014). 
For the last 15 years, the authors have focused on the quest for 
natural substances for the treatment of CL and their structural optimi-
zation by chemical transformations. The derivatization of 4-chromanone 
and 4-thiochromanone compounds with several hydrazides generated 
two chromane hydrazones 2-(2,3-dihydro-4H-1-benzothiopyran-4-yli-
dene) hydrazide (TC1) and 2-(2,3-dihydro-4H-1-benzopyran-4-ylidene) 
hydrazide (TC2), respectively (Fig. 1). Both compounds, formulated as 
1% aqueous solution or 4% ointment, showed a high therapeutic 
response when administered topically to hamsters with CL caused by 
L. braziliensis (Upegui et al., 2019). 
2. Materials and methods 
Several formulations were prepared to optimize the therapeutic po-
tential of the 4% TC1 and TC2 ointment, through the combination of 
each chroman hydrazide with the triterpene saponin mixture SS at ratios 
1: 1 (w/w), 1: 3 or 3: 1, hydrazone:saponin, respectively. The new for-
mulations of TC1 with SS, and TC2 with SS, were validated for their 
therapeutic response in the experimental CL model caused by 
L. braziliensis in the golden hamster. Finally, the effect of the compounds 
was evaluated individually, or in combination, on some biochemical 
processes of two species of Leishmania in various biological stages. 
Specifically, the effect on energy metabolism, response to cellular stress, 
interaction with the host cell, and activity in proteases were studied, as 
well as the reinfection process. 
2.1. Synthesis of chromane hydrazones TC1 and TC2 
Compounds were synthesized as reported (Vargas et al., 2018). 
Briefly, a solution of chromane or thiochromane-4-one, and the 
respective hydrazone were mixed in ethanol, and then, 5% acetic acid in 
ethanol was added dropwise. The reaction mixture was heated and then 
poured into an ice/water, filtered, dried and crystallized. Compounds 
were identified by 2D NMR and MS (Echeverri et al., 2015). 
2.2. Isolation and purification of the triterpene saponin 
The saponin SS was obtained according to the procedure reported by 
Correa et al. (2014) by the extraction of arillus with ethanol and puri-
fication by sephadex LH-20 followed by column chromatography using 
CH2Cl2–MeOH (9:1 v:v) on silica gel. A fraction containing an equimolar 
mixture of three saponins was obtained, differing on the substitutions of 
the glycosidic moiety of the molecule (Fig. 1). 
2.3. Cells and culture 
The U937 (human promonocyte, CRL-1593.2) and J774 (mouse 
macrophage, TIB-67) cell lines were grown under standard conditions in 
RPMI-1640 or DMEM, respectively, supplemented with 10% heat- 
inactivated fetal bovine serum (FBS) and antibiotics (100 U/mL peni-
cillin and 0.1 mg/mL streptomycin). Hamster’s peritoneal macrophages 
(haPDM) were obtained after intraperitoneal injection of 0.4% sodium 
thioglycollate in phosphate buffer saline (PBS) (Mesa et al., 2010) and 
cultured in RPMI medium with 10% FBS and 1% antibiotics. All cell 
types were incubated at 37 �C in the presence of 5% CO2. 
2.4. Parasite strain and culture 
Wild type L. braziliensis wild type (MHOM/CO/88/UA301-wt), 
L. braziliensis green fluorescent protein transfected (MHOM/CO/88/ 
UA301-EGFP), L. braziliensis luciferase transfected (MHOM/CO/88/ 
UA301-luc) and L. pifanoi (MHOM/VE/60/Ltrod) were used in the 
present work. 
L. braziliensis was cultured as promastigotes in NNN (Novy-McNeal- 
Nicolle) biphasic medium at 26 �C, with a change of medium every 15 
days. The L. pifanoi axenic amastigotes were grown in 199 medium 
supplemented with 1.25 g/L glucose, 2.5 g/L trypticase, 500 μL/L 
gentamicin, 0.375 g/L glutamine, 25 mg/L hemin and 10% of FBS 
(complete medium) and incubation at 32 �C in a wet chamber 
(Luque-Ortega and Rivas, 2010). The medium was changed every day to 
keeping parasites in exponential growth phase. 
2.5. In vitro cytotoxic activity 
Cytotoxicity of TC1, TC2, SS and TC1:SS and TC2:SS (1:1 ratio) was 
measured in U937, J774 and haPDM cells by inhibition of 3-(4,5- 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduc-
tion assay as described elsewhere (Upegui et al., 2014). Cells exposed to 
doxorubicin and Amphotericin B (AMB) were used as positive (cyto-
toxicity) controls while unexposed cells were used as negative (viability) 
control. The negative control was performed using growth medium 
alone. Compounds were dissolved in DMSO (1 mg/mL, w/v) and then 
was prepared a stock solution of 200 μg/mL complete RPMI-1640 me-
dium; serial four-fold dilutions were made from stock solution to give 
working concentrations of 200–0.78 μg/mL. Thus, the final concentra-
tion of DMSO in the tested dilutions was not higher than 0.2% which has 
been widely demonstrated not be toxic for cells (Hajighasemi and Tajic, 
Fig. 1. Structure of compounds. A. A mixture of saponins; B: Chroman 
hydrazone derivatives, TC1 and TC2. 
Y.A. Upegui Zapata et al.                                                                                                                                                                                                                     
International Journal for Parasitology: Drugs and Drug Resistance 13 (2020) 94–106
96
2017). Non-specific absorbance was corrected by subtracting absor-
bance (O.D) of the blank (RPMI-1640 plus 0.2% DMSO). Determinations 
were done by triplicate in at least two independent experiments. 
2.6. In vitro antileishmanial activity 
The activity of compounds was evaluated on promastigotes of 
L. braziliensis and L. pifanoi as well as in axenic amastigotes of L. pifanoi, 
using the MTT assay as described by others (Sereno and Lemesre, 1997). 
In this case, parasites at the log growth-phase were harvested and 
adjusted to 2 � 106 parasites/mL in complete RPMI-1640 (for promas-
tigotes) or 199 media (for axenic amastigotes). Promastigotes were 
incubated at 26 �C, while axenic amastigotes were incubated at 32 �C for 
72 and 96 h, respectively. 
The leishmanicidal activity was also evaluated on intracellular 
amastigotes of L. braziliensis. Briefly, U-937 cells were adjusted to 3 �
105 cells/ml in complete RPMI-1640 medium and 0.1 μg/mL of phorbol 
12 myristate 13 acetate. In each well of a 24 well plate containing a 
microscope cover glass, was dispensed 1 mL of cells and plates were 
incubated for 72 h at 37 �C and 5% CO2. Cells were then infected with 
promastigotes at 13:1 parasite/cell ratio. Cells exposed to parasites were 
incubated for 3 h at 34 �C, 5% CO2. Each well was washed three times 
with prewarmed PBS to remove non-internalized parasites, and new 
medium was added. After 24 h of infection, cells were exposed to four 
dilutions starting at 50 μg/mL of each compound or their combinations 
and incubated again for 72 h at the corresponding temperature. Cells 
were removed from the bottom well with trypsin/EDTA solution, 
washed by centrifuging with 1 mL/well of PBS and suspended in 500 μL/ 
well of PBS. Plates were read in a flow cytometer (Cytomics FC 500MPL, 
Brea, CA), at 488 nm excitation and 525 nm emission and counting 
10,000 events Pulido et al., 2012). Infected cells exposed to AMB were 
used as an internal assay control for leishmanicidal activity. 
2.7. Formulations of TC1 and TC2 combined with SS 
Ointments were prepared based on a mixture of lanolin and petro-
latum 2: 1 (w/w) and 1% glycerin. For the preparation of the mixtures, 
the solids of the pure chromane hydrazones or the saponin mixture were 
combined and subsequently incorporated into the base ointment; those 
same solids were used for in vitro assays. In this way, three formulations 
were obtained, each containing 4% of the mixture of the active in-
gredients TC1 or TC2 and SS in a ratio 1: 1, 1: 3 and 3: 1 chromane 
hydrazone:saponin (w/w). 
2.8. In vivo antileishmanial activity 
The antileishmanial response of compounds was evaluated in juve-
nile male and female golden hamsters (Mesocricetus auratus) experi-
mentally infected with L. braziliensis, using the method described by 
Robledo et al. (2012). In this model, those hamsters that self-limiting 
infections and do not develop an ulcer are excluded. Only hamsters 
that develop an ulcer with a diameter greater than 4 mm2 were 
randomly distributed in seven treatment groups (n ¼ 5 animals per 
group). Seven groups were treated topically with 40 mg/day of each 
ointment preparation for 28 days while the remained group of hamsters 
was treated with meglumine antimoniate (MA), administered intrale-
sional, at 200 μg/three times per week for 28 days (MA-28). After the 
end of treatment, animals were supervised for 90 additional days. From 
the beginning of the treatment, the hamsters were observed daily to 
record survival and changes in behavior. The effectiveness and toxicity 
of each compound was determined according to the evolution of the 
lesion size and body weight during the study. For this, the area (width 
and length) of the ulcer and the body weight were recorded before 
treatment (D0), the last day of treatment (TD28) and every 30 days 
during 3 months. The effectiveness of each treatment was assessed in 
terms of reduction or disappearance of the ulcer in each hamster. The 
outcome at the end of study was recorded as a cure (epithelial healing 
and emergence of fur); improvement (reduction of the lesion size by at 
least > 20%); relapse (reactivation of the lesion after initial improvement 
or cure); or failure (increase of the lesion size). 
The Ethics Committee for Animal Experimentation at the Uni-
versidad de Antioquia approved all of the experiments conducted with 
the hamsters (Act No. 91 of September 25, 2014). 
2.9. Effect of TC1, TC2, SS and their combinations in morphology and 
functions of Leishmania spp 
2.9.1. Morphology of Leishmania pifanoi 
The effect of the compounds was determined in both axenic and 
intracellular amastigotes of L. pifanoi but also in non-infected cells using 
TEM and fluorescence microscopy. The axenic amastigotes were grown 
under standard conditions, then adjusted to 2 � 106 amastigotes/mL and 
incubated with the compounds at a concentration equivalent to their 
effective concentration 70 (EC70) to ensure a response without causing a 
cytotoxic effect on the host cell. 
On the other hand, 200,000 J774 cells/mL (DMEM medium with 
10% FBS and 1% antibiotics) were seeded in each well of a 24-well plate 
containing microscope cover glass. The cells were incubated at 37 �C, 
5% CO2 for 24 h and then macrophages were infected with axenic 
amastigotes in a 4:1 ratio (parasite per cell) and incubated for 4 h at 32 
�C in a wet chamber. Non-internalized parasites were removed by PBS 
washing four times with 1 mL PBS; then 1 mL of RPMI-1640 medium 
with 10% SBF was added, and cells were incubated for additional 24 h. 
For TEM analysis, axenic amastigotes and infected cells were washed 
and fixed with 3% glutaraldehyde (1 h, 4 �C) followed by increasing 
dehydration steps (Luque-Ortega and Rivas, 2010). The samples were 
embedded in Epon 812 resin and observed in TEM (JEOL-1230 USA Inc. 
MA, USA). 
For fluorescence analysis, axenic amastigotes and infected cells were 
washed with Hanks-Buffer (155 mM NaCl, 1 mM MgCl2, 10 mM HEPES). 
The equivalent concentration of the treatment was put in the buffer 
solution to guarantee the maintenance of the system, and with this so-
lution the washes and staining at 100 nM of Lysotracker network were 
carried out for 30 min, incubating at 32 �C, protected from light. The 
reading was done by observation under a fluorescence microscope 
(Nikon eclipse). Staining with nigericin (10 μM) during 10 min was used 
as positive control (Vercesi et al., 2000). Light and dark field photo-
graphs were registered. 
2.9.2. Plasma membrane integrity 
100 μL of the L. pifanoi axenic amastigotes (2 � 107 parasites/mL in 
Hanks-Glu medium plus 1 μM of the Sytox Green probe) were trans-
ferred to each well of a 96-well plate to determine the effect of the 
different compounds and mixtures of compounds on plasma membrane 
permeabilization. Next, 100 μL of each compound or combination 
thereof was added at 50 μg/mL. Plates were read every 60 s for 1 h at 
485 nm excitation and 520 nm emission using a microplate reader (Polar 
Star Galaxy, BMG, Germany). To detect changes in fluorescence caused 
by the hybridization of the probe to the DNA, Triton X-100 (1%) was 
used as control to membrane permeabilization and to define the 
maximum fluorescence signal for each well. 
The effect on membrane permeabilization was also evaluated in 
promastigotes of L. braziliensis-EGFP. In this case, the measurements 
were made at 1, 2 and 24 h. Here, 300 μL of the parasites were exposed 
to the compounds and their combinations and then centrifuged at 
1000�g for 10 min and suspended in 300 μL of propidium iodide at 50 
μg/mL. After 15 min of incubation at 25 �C and in the dark, fluorescence 
was recorded by reading at 488 nm excitation and 610 nm emission. 
2.9.3. Intracellular ATP variation 
Promastigotes of L. braziliensis-Luc in the log phase-growth were 
adjusted to 2 � 107 parasites/mL in Hansk-Glu solution. The ({D- 
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luciferin-1 [- (4,5-dimethoxy-2-nitrophenyl) ethyl ester)}) (DMNPE) 
substrate - luciferin was added at 50 μM and then, 90 μL of the parasite 
solution was transferred to each well of a 96-well microplate; the 
luminescence was read, and then compounds or combinations at 50 μg/ 
mL were added to each well. Plates were read every 60 s for 1 h in the 
microplate reader (Varioskan Flash, Thermo Fisher Scientific, USA). 
Parasites in untreated Hanks buffer supplemented with 10 mM D- 
glucose solutions were included as control. Triton X-100 (1%) was used 
as a permeability control and Naphthoquinone (1.5 μM) was used as 
control for mitochondrial involvement (Luque-Ortega et al., 2001). 
2.9.4. Mitochondrial membrane potential (ΔΨm) 
The effect in the mitochondrial membrane potential (ΔΨm) was 
evaluated in axenic amastigotes of L. pifanoi using the Rhodamine 123 
(Rh 123) staining method (Carvalho et al., 2011) and in intracellular 
amastigotes of L. braziliensis using the Tetramethylrhodamine Methyl 
Ester (TMRM) probe. 
Axenic amastigotes of L. pifanoi were adjusted to 2 � 107 parasites/ 
mL in 199 medium and incubated in the presence of each compound at a 
concentration equivalent to the corresponding EC70 for 1 h and 4 h at 32 
�C. Parasites incubated with 20 mM KCN for 40 min were used as con-
trol. Then, parasites were washed twice with PBS and centrifuged at 
15,000�g for 4 min at 25 �C. The supernatant was discarded, and the 
pellet was resuspended in 1 mL of the Rh 123 solution at 0.3 μg/mL, 
incubated at 32 �C for 10 min and centrifuged again for washing with 
PBS and 1% bovine serum albumin (BSA). Pellet was suspended in 200 
μL of PBS and transferred to a microplate for reading at 488 nm exci-
tation and 520 nm emission. 
The intracellular amastigotes of L. braziliensis were mechanically 
released from the U937 macrophages using a syringe plunger. The cell 
lysate was centrifuged at 100�g for 5 min; the supernatant was dis-
carded and pellet was centrifuged again for 10 min at 1500�g. Free 
amastigotes were adjusted at 4 � 106 parasites/mL in RPMI-1640 me-
dium free of phenol red, pH 5.5, and supplemented with 10% FBS and 
1% antibiotics. In each well of a 96-well microplate were dispensed 100 
μL of the parasite suspension and then, 100 μL of each compound at a 
concentration equivalent to EC90 were added. Plates were incubated for 
1 h or 4 h. Parasites incubated with 20 mM NaCN for 30 min were used 
as control. Then, 100 μL of TMRM probe 100 μM were added and plates 
were incubated at 34 �C for 20 min. The plates were centrifuged at 
1200�g for 8 min and resuspended in 100 μL of PBS, transferred to a 
dark 96-well plate and fluorescence was read at an excitation of wave-
length 548 nm and 573 nm emission. 
2.9.5. Reactive oxygen species production 
The generation of reactive oxygen species (ROS) was assessed by 
flow cytometry in axenic amastigotes of L. pifanoi and mechanical 
released amastigotes of L. braziliensis, using the 2070-dihydrofluorescein 
(H2DCF-DA) probe (Carvalho et al., 2011). The dichlorofluorescein 
resulting from the oxidation of H2DCF-DA by ROS in L. pifanoi was 
quantified in the microplate reader (Varioskan Flash, Thermo Fisher 
Scientific, USA) at a wavelength of 495 nm excitation and 527 nm 
emission. In L. braziliensis, the amount of dichlorofluorescein was 
measured in a flow cytometer (LSR Fortesa, BD Biosciences, USA), ac-
cording to the median fluorescence intensity (MFI). Antimycin (0.3 
μg/mL) was used as control in L. pifanoi, while rotenone (50 μg/mL) was 
used as control in L. braziliensis experiments. 
2.9.6. Lipid bodies formation 
The formation of lipid bodies was determined in axenic amastigotes 
of L. pifanoi and mechanical released amastigotes of L. braziliensis and 
staining with Nile red, following the methodology described by Godinho 
et al. (2013). Plates were read in a microplate reader (Varioskan Flash, 
Thermo Fisher Scientific, USA) at an excitation wavelength of 485 nm 
and emission of 538 nm. 
2.9.7. Proteolytic activity 
Promastigotes of L. braziliensis adjusted at 2.5 � 106 parasites/mL of 
Schneider medium with 10% FBS, were incubated for 2 h at 26 �C, in the 
presence of each compound, at the equivalent concentration to EC90 
determined in promastigotes. Proteins were quantified using the 
Pierce™ BCA Protein Assay Kit (Thermo Scientific) using BSA as protein 
standard. The reaction was read at 595 nm in a microplate reader 
(Varioskan Flash, Thermo Fisher Scientific, USA). Proteins were stored 
at   80 �C until use. 
The zymographic study was carried out according to the methodol-
ogy proposed by Cuervo et al. (2006), with some modifications. Briefly, 
60 μg of Leishmania proteins were suspended in 60 μL of sample buffer 
containing 100 mM TRIS-HCl pH 8.0, 150 mM NaCl, 10% Glycerol, 0.6% 
Triton X-100, and bromophenol and incubated at room temperature for 
1 h. Then, 20 μL of the buffer with 30 μg of protein was run in 10% 
SDS-PAGE copolymerized with 0.1% gelatin for 105 min at constant 
120 V. After electrophoresis, gels were washed twice with 0.1 M sodium 
acetate pH 5.5 at 2.5% Triton X-100 for 30 min at 4 �C. After this, gels 
were washed four times with distilled water to remove detergent res-
idue. Gels were placed in reaction buffer, 0.1 M sodium acetate, 1 mM 
DTT at pH 5.5, 37 �C for 24 h to allow protease activity. Finally, gels 
were stained with Coomassie blue for 20 min at room temperature. 
Protease activity was evidenced as uncolored zone in the gel due to the 
degradation of the gelatin. 
This same procedure was performed in the presence of two cysteine 
protease inhibitor: leupeptin and trans-epoxysuccinyl-L-leucylamido-(4- 
guanidino)-butane (E  64). For this, after washing, gels were incubated 
in the reaction buffer containing 25 μM of leupeptin or ten μM of E  64 
at 37 �C for 4 and 2 h, respectively. The gels were washed again as 
previously described and incubated in the reaction buffer at 37 �C for 24 
h. Finally, gels were stained with Coomassie blue and the gels were 
visualized for the inhibition of the degradation of the gelatin caused by 
the corresponding family of proteases. 
For cysteine proteases assay, mild log phase (day 3) promastigotes of 
L. braziliensis were washed two times in ice-cold PBS for10 min, 1,500�g 
in a Sorvall RT6000 centrifuge, and re-suspended in 100 mL of M199 
medium supplemented with 10% FBS at 1 � 106 parasites/mL. Parasites 
were incubated with 50 μg/mL of compounds for 2 h at 25 �C. Controls 
were untreated or incubated with same volume of dimethyl sulphoxide 
(DMSO) used to re-suspend and adjust drug concentration (100 μL). For 
preparation of lysates, parasites were pelleted, washed in PBS, and re- 
suspended in fresh lysis buffer (20 mM Tris pH 8.0, 10 mM EDTA, pH 
8.0, 4 mM NaCl) at 5 � 108 parasites per 300 μl of buffer. Lysates were 
left on ice for 30 min, sonicated in 3 cycles (30 s/cycle, 30 s cooling in 
between; 45 mv) and centrifuged at 21,000�g for 20 min to remove cell 
debris. Protein concentration was assessed by Pierce™ BCA Protein 
Assay kit. 
The enzymatic activity of L. braziliensis lysates was assayed with the 
fluorogenic synthetic substrate Z-Phe-Arg-amidomethylcoumarin 
(AMC), as previously described (Somanna et al., 2002). Fluorescence of 
Z-Phe-Arg-AMC liberated from the substrates during proteolytic activity 
was determined by ELISA reader every 5 min up to 30 min at 460 nm 
emission and an excitation wavelength of 355 nm. 
2.9.8. Reinfection capacity 
Five x106 PMA activated U937 cells were infected with L. braziliensis- 
EGFP promastigotes as described above, 72 h post infection. The infec-
ted cells were exposed to each compound at the corresponding EC50 
concentrations for 24 h. After that, cells were washed with PBS, and the 
amastigotes were mechanically released. Cell lysates were washed with 
PBS and centrifuged at 1500�g for 8 min. The amastigotes were adjusted 
to 2.25 � 106 amastigotes/mL in RPMI-1640 medium with 10% FBS. 
Four hundred μL of the parasite suspension was added in each well of a 
24-well plate containing 100,000 U937 macrophages previously 
differentiated with PMA (3:1 parasite: cell ratio). After 24 h of incuba-
tion at 34 �C, 5% CO2 wells were washed with PBS to eliminate non- 
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internalized parasites and cell debris, and the medium was replaced with 
fresh RPMI-1640 with 10% FBS. Plates were incubated for additional 96 
h at 34 �C, 5% CO2. After this, cells were detached and the number of 
infected cells as well the number of parasites in the infected cells were 
determined according to the green fluorescent events and the MFI by 
flow cytometry, as previously described (Pulido et al., 2012). 
2.10. Data analysis 
Each experiment was performed in triplicate in at least two inde-
pendent experiments. Data are expressed as the average value � the SD. 
The cytotoxic and antileishmanial activity was determined according to 
the median lethal concentration (LC50) and the median effective con-
centration (EC50) obtained by Probit analysis, following the methodol-
ogy described by Upegui et al. (2019). For the analysis of the data, 
comparisons were made between groups using two-way ANOVA, as well 
as the Bonferroni’s test for comparisons between groups of parametric 
data or Kruskal Wallis test for non-parametric data. Differences with a 
p-value <0.05 were considered as statistically significant. 
3. Results 
3.1. Cytotoxicity and antileishmanial activity 
The cytotoxicity showed by TC1, TC2, and SS compounds, both 
individually and in combination, on the U937 and J774 macrophage cell 
lines was classified as moderate, with LC50 values between 40 and 150 
μg/mL (Table 1). For haPDM, TC1 and TC2 showed low cytotoxicity, 
with LC50 values > 200 μg/mL while SS showed high cytotoxic activity, 
with an LC50 of 33.9 � 4.6 μg/mL; the cytotoxicity of the combinations 
in the haPDM was moderate, with LC50 values of 127.4 � 10.2 and 181 
� 5.0 μg/mL for TC1:SS and TC2:SS, respectively). In turn, the com-
pounds were active only in the amastigote stage, with activity between 
high (<25 μg/mL) and moderate (>25 and <50 μg/mL) (Table 1). The 
combination of the compounds showed reductions of their EC50 around 
50% The highest activities were observed for intracellular amastigotes 
of L. braziliensis, but the SS showed low activity for axenic amastigotes of 
L. pifanoi. 
3.2. In vivo therapeutic response of a combination of TC1 or TC2 and SS 
The combination of TC1 or TC2 with SS was evaluated in three 
different combinations 1:1, 1:3, and 3:1 (w/w ratio) (chromane hydra-
zone:saponin, respectively). Regarding TC1 combinations, the ratio 1:1 
was the most effective treatment, with 100% cure when applied daily for 
30 days. These results are similar to meglumine antimoniate (MA), used 
as antileishmanial control (Fig. 2). The other treatments were less 
effective, thus 1:3 combination caused a 60% cure in slow response, and 
the 3:1 combination showed the lowest efficacy, including several 
relapses. Concerning TC2 combinations, all treatments were less effec-
tive than TC1 combinations and cure process was slower. The other 
combinations with this compound, 1:3 and 3:1 were unsuccessful and 
included high relapsed cases. Treatment with intralesional MA every 
two days for 28 days (MA-28) produced cure in 3/5 hamsters (60%) and 
failure and improvement each in the remained two hamsters. In short, 
combinations of TC1:SS in 1:1 combination displayed a high and fast 
affectivity against L. The combinations in 3:1 ratio did produce the 
poorest therapeutic response, with only 40% and 20% cure for TC1: SS 
and TC2: SS, respectively. 
3.3. In vivo toxicity of treatments 
Treatment with different combinations of compounds TC1 or TC2 
with SS did not produce any detrimental effect on body weight in most 
hamsters, but rather a slight weight gain (4–30%) was observed in all 
groups of treatments. The evolution of the body weight in the treatment 
group is shown in Fig. 3. The parameters of renal and hepatic function 
ALT, creatinine, and BUN, did not show any alteration because of the 
treatment (data not shown). 
3.4. Morphological changes in infected macrophages and axenic 
amastigotes of L. pifanoi 
Infected J774 macrophages treated with TC1 and TC2 for 24 h 
showed an increase in cell size and elongation, with numerous degra-
dation vacuoles. we also observed a decrease in phagolysosome size 
(Fig. 4A and B) and, apparently, loss of its content compared to the 
control without treatment (Fig. 4C). Abundant glycosomes were detec-
ted in the parasites as electro-dense structures. Infected macrophages 
treated with SS showed abundant empty vacuoles (Fig. 4D). In the 
combinations, empty vacuoles were abundant with little alteration of 
the phagolysosome morphology and degradation vacuoles; the parasitic 
load was low in TC1: SS (Fig. 4E). In the case of TC2: SS cells, more than 
one amastigotes were observed (Fig. 4F). 
No statistically significant association was found between the control 
of infected cells and the control of depolarization of nigericin acid 
compartments (Fig. 5A and B) with the treatments (5C-G) regarding the 
change in pH or the number of lysosomes, thus suggesting the absence of 
changes in the acidity of this compartment. However, compared to the 
controls of infected cells (Fig. 5A), a shift towards a single cell pole was 
observed mainly in cells treated with the combinations of TC1:SS and 
TC2:SS (Fig. 5F and G). An increase in the Arbitrary Fluorescence Units 
(AFU) were observed in cells treated with TC2:SS combination, which 
could suggest a better functionality of this compartment to eliminate the 
parasite. 
The TEM analysis of axenic amastigotes showed three important 
facts: i) compounds, mainly SS, modified the morphology of amasti-
gotes, even increasing their size (Fig. 6A and B), ii) there was an increase 
Table 1 
Cytotoxicity and sensitivity of Leishmania to chromane derivatives TC1and TC2 and triterpene sapogenin.  
Compound CL50 μg/mL CE50 μg/mL aIS 
L. braziliensis L. pifanoi 
U937 J774 HaMDP Promastigotes Intracellular amastigotes Axenic amastigotes 
TC1 88.1 � 3.6 83.7 � 2.4 >200 69.8 � 6.7 12.1 � 4.1 17.9 � 3.1 7.3 
TC2 85.1 � 3.7 72.9 � 2.4 >200 99.9 � 4.8 25.5 � 0.9 13.2 � 4.2 3.3 
SS 63.5 � 1.2 43.9 � 2.9 33.9 � 4.6 135.5 � 5.6 20.8 � 6.4 >50 3.1 
TC1:SS 70.4 � 1.8 81.2 � 0.2 127.4 � 10.2 108.7 � 4.5 7.7 � 2.4 13.4 � 3.7 9.1 
TC2:SS 99.7 � 1.9 145.7 � 9.9 181.0 � 5.0 114.9 � 8.5 13.6 � 6.8 17.1 � 5.3 7.3 
Doxorubicin 0.13 � 0.0 0.5 � 0.01 0.06 � 0.01 NA NA NA NA 
Amphotericin B 28.8 � 1.2 52.7 � 3.7 17.8 � 3.2 3.4 � 0.6 0.7 � 0.1 NA 41.7 
Miltefosine 104.6 � 11.7 28.3 � 3.3 3.9 � 0.8 NA NA 0.04 � 0.0 261.5 
Data represent the median lethal and effective concentration (LC50, EC50) in μg/mL for each compound � SD. 
a IS: Index of selectivity calculated by CL50 in U937/CE50 in intracellular amastigotes. 
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in the number of electro dense vacuoles in the treated parasites (Fig. 6B, 
D); and iii), the effect of SS in the mitochondria was confirmed struc-
turally, evidenced as swelling of its membrane (Fig. 6C figs1). 
3.5. Effect of chromane TC1 and TC2 and saponin SS in energy 
metabolism 
The compounds combination produced a rapid decrease in ATP 
levels close to 30%. SS produced a strong depletion of ATP levels, even at 
levels comparable to naphthoquinone control (Fig. 7A). The integrity of 
the plasma membrane was evaluated, without finding significant effects 
on it in the different Leishmania species evaluated to determine the 
possible origin of this decrease (Fig. 7B). When the functionality of the 
mitochondria was studied after compounds addition, a decrease in 
intracellular accumulation of rhodamine 123 was observed due to 
changes in the mitochondrial electrochemical potential. The SS mixture 
caused a significant loss of mitochondrial membrane potential after 1 h 
of incubation, while TC1 and TC2 only caused this effect when used in 
combination with SS and after 4 h of incubation (Fig. 7C). This effect of 
loss of mitochondrial membrane potential was also observed in intra-
cellular amastigotes of L. braziliensis when evaluated by staining with 
TMRM (Fig. 7D). 
3.6. Effect of chromane TC1 and TC2 and saponin SS in cell stress 
Cellular stress was determined according to the production of ROS 
Fig. 2. Efficacy of an ointment of hydrazones TC1 and TC2 in combination with a mixture of triterpene saponin (SS) vs. meglumine antimoniate (MA) in a 
L. braziliensis-hamster model of cutaneous leishmaniasis. Data show the evolution of the lesion according to the size in mm2 after topical treatment with 40 mg of 
4% ointments TC1:SS or TC2:SS (1:3), TC1:SS or TC2:SS (1:1) and TC1:SS or TC2:SS (3:1) every day for 28 days or MA (200 μg every three days, during 28 days) (MA- 
28). The effectiveness of each treatment was assessed, comparing the lesion sizes before and after treatment for everyone. The area (width and length) of the ulcer 
were recorded before treatment (D0), the last day of treatment (TD28) and every 15 days during 3 months. Nevertheless, only TD0, TD28 and post-treatment days 
(PTD) 90 are shown in the figure because these are the most relevant time points to show changes related to effectiveness of the treatment. The final outcome 
observed at the PTD90 was recorded as cure (epithelial healing and emergence of fur); improvement (reduction of the lesion size by at least > 20%); relapse (reac-
tivation of the lesion after the initial improvement or cure); or failure (increase of the lesion size). All combinations were made w/w percentage; final percentage of 
compounds in the ointment was 4%. MA was administered by intralesional route. MAI, MAD, MPI and MPD refer to the brand that identifies each hamster and the 
number that accompanies these letters corresponds to the cage were hamsters are housed. 
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and the formation of lipid bodies. ROS production was measured as the 
appearance of fluorescence resulting from oxidation of the H2DCF-DA 
probe. All treatments induced oxidative stress, being more evident in 
axenic amastigotes of L. pifanoi, wherewith only 1 h of incubation, ROS 
levels increased up to five times compared to the control without 
treatment. On the other hand, L. braziliensis amastigotes showed a later 
and discreet response, generating at 1 h of incubation almost double the 
amount of ROS concerning basal production, which increased a little 
more at 4-hour post-exposure. For L. braziliensis, the evaluation was 
performed by flow cytometry, observing that at 1 h of incubation only 
5% of the population increased the production of ROS, while the rote-
none used as a control was 87%. At 4-hour post-treatment, the per-
centage of positive events was 95.5% for rotenone, 22.1% for TC1, 
31.4% for TC2, 20.8% for SS, 23.1% for TC1:SS, and 25.2% for TC2:SS, 
respectively. In all treatments, there was an increase in UAF for lipid 
bodies detected by staining of Nile red, after 24 h of exposure (Table 2). 
Fig. 3. Effect of the treatment on body weight. 
Golden hamsters (n ¼ 5 each group) were treated 
for 28 days with 40 mg of three different combi-
nations (1:3, 1:1 or 3:1) of hydrazonesTC1 or TC2 
and SS, respectively, topically; MA-28 (200 μg every 
three days, 28 days, intralesional). The data repre-
sent the mean value � SD of the weight in grams of 
the hamsters in each experimental group. p > 0.05. 
Bodyweight was measured before the treatment 
(D0) at the end of the treatment (D28) and every 30 
days for three months, corresponding to post- 
treatment days (PTD) 30, 60, and 90.   
Fig. 4. Transmission electron microscopy of J774 macrophages infected with L. pifanoi. A and B. TC1 and TC2 treatments caused loss of phagolysosome 
bulkiness, abundant electrodense vacuoles. C Control without treatment. D. SS treatments with empty vacuoles, E. TC1:SS (1:1), F. TC2:SS (1:1). The images are 
representative of the findings for each treatment group. f: Phagolysosome N: Macrophage nucleus n: L. pifanoi nucleus k: Kinetoplast pf: Flagellar pocket Vd: Parasitic 
degradation vacuums. The white arrows indicate the thinning of the phagolysosome (A) and the empty vacuoles (D, E and F). 
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3.7. Effect of chromane TC1 and TC2 and saponin SS in proteases 
A complete inhibition of the proteases activity in promastigotes of 
L. braziliensis was observed after 2 h of exposure to SS. The inhibitory 
effect was evidenced by the disappearance of a band with a relative 
weight between 32 and 46 kDa (Fig. 8A). In contrast, hydrazones TC1 
and TC2 only reduced the protease activity. Since a similar activity was 
observed for Leupeptin and E  64 protease inhibitors (Fig. 8B), the re-
sults suggest that the inhibitory effect caused by SS and hydrazones TC1 
and TC2 occurs on cysteine proteases. This protease inhibition was 
related to a decrease in the parasite’s ability to infect cells, as described 
below. Thus, the exposure of infected cells to compounds TC1 and SS for 
24 h, and the subsequent release of the amastigotes to reinfection of 
cells, a significant decrease in the infective capacity of these pre-treated 
amastigotes, was observed. The percentage of infected cells in the 
absence of treatment was 47.5 � 4.9 while in the treated cells was 15.6 
� 3.4 for TC1, 36.7 � 0.8 for TC2, 23.1 � 0.1 for SS, 36.6 � 4.8 for TC1- 
SS and 34.1 � 5.9 for TC2-SS (Fig. 8C). 
On the other hand, the percentage of cells infected with parasites 
pretreated with AMB was 23.4 � 0.8, and the percentage of decrease in 
reinfection was 68% for TC1, 22.7% for TC2, 22.9% for TC1:SS, 28.2% 
for TC2:SS and 50.7% for parasites exposed to AMB. The most potent 
compound was TC1, while combinations or TC2 only achieved a 
response close to 30% of this value. 
Besides, the decrease in the number of infected cells was directly 
proportional to the MFI. Cells infected with the pre-treated amastigotes 
pretreated with TC1 and SS showed 4 and 5 times less amount of par-
asites, respectively (Fig. 8D). The MFI values obtained for each 
treatment were: 9.9 � 1.2 (untreated cells); 1.8 � 0.1 (cells infected and 
treated with TC1); 8.3 � 0.2 (cells infected and treated with TC2); 2.7 �
0.2 (infected and treated cells with SS); 6.1 � 1.7 (cells infected and 
treated with TC1-SS); 4.8 � 0.7 (cells infected and treated with TC2-SS), 
and 2.6 � 0.01 (cells infected and treated with amphotericin B, AMB). 
In summary, the overall inhibitory potency of chromane or combi-
nation is TC1> SS > TC2: SS > TC1: SS > TC2. Even TC1 was more active 
than AMB, and SS was similar to this drug. 
The evaluation of the inhibition of the enzymatic activity of cysteine 
proteases, in total lysates of promastigotes of L. braziliensis after 2 h of 
exposure to treatments, shows that there is a very subtle effect of all 
treatments on cysteine proteases (Table 3). The best effect was observed 
with TC1. Compound CA074 exerts a potent inhibitory action on the 
cysteine protease cathepsin B, thus indicating non-specific activity 
against this enzyme on the compounds assayed. These findings did not 
allow to correlate the inhibition observed in the zymography of 
L. braziliensis, with cathepsin B [ inhibition band of around 34 kDa], 
suggesting inhibition in other proteases or isoforms. 
4. Discussion 
The WHO has classified 19 diseases as Neglected Tropical Diseases 
(NTD), which are associated with poverty in tropical and subtropical 
countries, and for which there are difficulties in accessing good and 
effective treatments. These diseases causing a global burden of 47.9 
million people and 152,000 annual deaths (Malecela, 2019). In 
Colombia, the main NTDs caused by protozoa are leishmaniasis and 
Chagas disease. 
Fig. 5. Characterization of acid compartments on parasitophorous vacuoles. The figure shows images of J774 macrophages with amastigotes of L. pifanoi 
labeled with LysoTracker. A. Control, B Positive control cells were incubated with Nigericin 10 μM. C: TC1, D: TC2, E: SS, F: TC1:SS, G: TC2:SS. Red arrows indicated 
the polar localization of the acid compartment in the cells. The numbers in the image correspond to the AUF (arbitrary units of fluorescence) by analysis in ImageJ. 
(For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) 
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A few therapeutic alternatives are available for the treatment of 
leishmaniasis. Although from the academic field, intense activity is 
developed in the search for new pharmacological alternatives, so far no 
alternatives have been generated to be developed clinically. In the last 
fifteen years, the authors of the present work have dedicated themselves 
to chemically optimized several molecules, starting from natural sub-
stances. After that, high curative activity of cutaneous leishmaniasis has 
been found both in vitro studies and the model of experimental LC in 
hamsters by application of several hydrazones and mixtures of tri-
terpene saponins. Given the therapeutic potential, it is essential to know 
the biochemical effects that these substances exert in the parasite and 
eventually in the host cell, to understand the mode of action of these 
molecules and, therefore, its role as drug candidates. 
The development of therapeutic alternatives for NTD, especially 
against cutaneous leishmaniasis, CL has been intensified in the last 15 
years, and yet there is no new topical or oral treatment commercially 
available. A strategy to increase the effectiveness of medications is the 
use of combined therapies acting on different targets simultaneously 
(Sundar and Chakravarty, 2013). With this, in addition to increasing the 
effectiveness, reductions in the dose, the length of treatment, side ef-
fects, and especially the induction of resistance, also will be achieved, 
could with less health care costs. 
Combined therapies in leishmaniasis have been studied both using 
endorsed medications or combinations of these with new compounds, 
finding few promising results (Momeni et al., 2002; Machado et al., 
2018; Dastgheib et al., 2012; Firooz et al., 2006). The use of oral pen-
toxifylline plus glucantime IM for 20 days (Sadeghian and Nilfor-
oushzadeh, 2006), and oral ketoconazole plus intralesional glucantime 
(El-Sayed and Anwar, 2010) are some examples of combined therapies 
that have shown better therapeutic efficacy are Even so, to date, no 
combination therapy is recommended in the pharmacological care 
guidelines. 
This work was aimed to evaluate the therapeutic potential and mode 
of action of TC1 and TC2 chromane hydrazones, recently identified with 
antileishmanial potential for the topical treatment of CL (Upegui et al., 
2019) and triterpene saponins previously reported also with anti-
leishmanial activity (Correa et al., 2014). Different therapeutic targets 
were evaluated for the mode of action: energy metabolism, cell stress, 
protease activity, and the reinfection process. 
The compounds proved to be selective on Leishmania spp. since all of 
them showed moderate cytotoxicity on macrophage lines and low 
cytotoxicity in primary cultures, the effectiveness was exclusive on the 
amastigote stage, with similar effects on the different Leishmania species 
evaluated. In the animal model, no toxic effect was evidenced after 90 
days’ post-treatment, and the healing of hamster back injuries were 
100% when using the 4% formulation in a 1: 1 ratio for combinations of 
TC1 or TC2 and SS. It was found that as the concentration of saponin 
decreases, the effectivity is reduced too, thereby showing that the SS has 
activity not only as a surfactant increasing the solubility of hydrazones 
but also has a direct effect on the viability of the parasite. The mea-
surement of parasite load in healed lesions is not considered because this 
model follows the parameters established in clinical trials in humans 
where the outcome of the cure is purely clinical. This is because it has 
been shown that up to now, no medication, not even approved for the 
treatment of leishmaniasis gives sterility and parasites can persist 
without it being associated with relapses. In this model the follow-up is 
carried out for three months after the end of treatment, a time that has 
proved to be sufficient time for identify recurrences if they occur. Proof 
of this is that in the present study, one of the hamsters of the group 
treated with MA who was cured at the end of the treatment showed 
reactivation in the evaluation on the 90th day after treatment. 
All compounds and their combinations affect processes associated 
Fig. 6. Transmission electron microscopy of axenic amastigotes of L. pifanoi after 24 h post-treatment. A. amastigotes without treatment, B: treated with TC1. 
C: Treated with SS. D: Bar graph of the ratio vacuoles per cell. The asterisk shows electro dense structures compatible with lipid bodies; the arrows show the swelling 
of the mitochondria. 
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with the functioning of mitochondria, an organelle that, in Leishmania, is 
primarily responsible for energy metabolism, since it provides 70% of 
ATP production. Also, it is involved in calcium homeostasis, redox bal-
ance, stress response and induction of apoptosis (Menna-Barreto and de 
Castro, 2014). Therefore, it has been defined as both essential and 
accessory targets in different trypanosomatids (Sundar and Singh, 
2018). Several drugs like pentamidine affect the biochemistry of the 
mitochondria; this compound is used for the treatment of African 
trypanosomiasis and leishmaniasis resistant to pentavalent antimonials. 
A collapse in the mitochondrial membrane potential is induced, leading 
to an imbalance in the intracellular calcium content (Vercesi et al., 
2000). In Leishmania, the intracellular calcium content is maintained 
due to the existing reserves between the endoplasmic reticulum, mito-
chondria, and acid-calcisomes (Docampo and Moreno, 2001). Pentam-
idine also inhibits mitochondrial complex II by inducing apoptosis 
(Mehta and Shaha, 2004). Likewise, miltefosine, a second-line medica-
tion for the treatment of leishmaniasis, affects the mitochondria by 
inhibiting the IV complex (cytochrome C oxidase), the last enzyme 
involved in electron transport (Luque-Ortega and Rivas, 2007). Its 
destabilization leads to the death of the parasite, although it also affects 
lipid metabolism since in trypanosomatids the synthesis of specialized 
fatty acids occurs in mitochondria (De Souza et al., 2009). 
Of the evaluated compounds, only the SS produced functional effects 
in ΔΨm as well as structural effects, evidenced as swelling of the 
organelle. It was ruled out that this effect was the result of alterations at 
the level of the integrity of the plasma membrane, using the sytox green 
technique. The accumulation of ROS in promastigotes of L. amazonensis 
Fig. 7. Energy metabolism in Leishmania after exposure to chromane hydrazones and a saponin mixture. Determination of the variation of ATP levels in 
promastigotes of L. braziliensis strain LUC. Under the conditions of the assay, luminescence levels are directly proportional to the intracellular concentration of ATP in 
the cytoplasm (A). Plasma membrane permeabilization test in amastigotes (L. pifanoi) and promastigotes (L. braziliensis): arbitrary units of fluorescence dependent the 
interaction between the SYTOX green probe and nucleic acids resulting from pore formation in the membrane, the compounds were applied at 50 μg/mL (B). 
Depolarization of the mitochondrial membrane in amastigotes of L. pifanoi (C) and amastigotes from L. braziliensis (D), the loss of the accumulation of the dye in the 
mitochondrial indicates changes in the membrane potential. AU: Arbitrary units; 1 h and 4 h: time of incubation of parasites in each treatment; NS: Non stained 
(negative control); NT: Non treated (negative control); Cþ: Positive control KCN (L pifanoi) NaCN (L. braziliensis). 
Table 2 
Induction of cellular stress by chromane derivatives (TC1and TC2) and tri-
terpene saponin (SS).   





































































The table shows the production index (baseline control without treatment and 
treatment ratio). 
a ROS: Reactive oxygen species determined with the H2DCF-DA probe. 
b Lipid bodies determined by Red Nile stain. 
c Positive control Antimycin A (0.3 μg/mL). 
d Rotenone (50 μg/mL). 
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and mitochondrial dysfunction have been observed with some hydra-
zones obtained from other nucleous than chromans (Coimbra et al., 
2018), but also in other chromans that directly affects the mitochondrial 
complex III (Monzote et al., 2011). 
The present work also demonstrated the occurrence of oxidative 
stress induced by the assayed molecules as a consequence of the 
blockade of the electron transport chain, which redirects the electrons of 
the respiratory chain towards their incorporation into oxygen and pro-
duction of reactive species. Said oxidative stress can act as a signaling 
stimulus, which in high concentrations supposes the induction of 
apoptosis (Menna-Barreto and de Castro, 2014). In the results obtained, 
it was observed that the axenic amastigotes of L. pifanoi and amastigotes 
released from L. braziliensis after 4 h of exposure to the compounds alone 
or in combination, maintain high levels of ROS, suggesting the parasite’s 
inability to balance again the redox balance, which could lead to death. 
This mechanism has been documented in pentavalent antimonials and is 
complemented by the loss of mitochondrial membrane potential and 
increased cytosolic calcium (Sudhandiran and Shaha, 2003). 
Also, it is important to highlight in this work the use of amastigotes in 
most the assays, since this stage in the vertebrate host is the target of the 
drug therapy. Usually, amastigotes are not used due to the difficulties for 
the axenic growth of the majority of the species and the complexity of 
working with infected macrophages. The amastigote of the Leishmania 
develops in the phagolysosome, a limited nutrient environment, in a 
metabolically quiescent state, and possess a higher resistance to 
different stress conditions, such as temperature and oxidative stress. In 
this compartment, there is a high degradation of proteins, free amino 
acids functioning as the main resource for survival (McConville and 
Naderer, 2011). On the other hand, the parasite is under the pressure of 
the oxidative defenses of the macrophage, which requires an adaptation 
to oxidative stress (Saunders et al., 2014). In this sense, we relate the 
results of oxidative stress in both axenic amastigotes and those released 
from the macrophage with the reduction of phagolysosome, which we 
believe would contribute to a greater concentration of intravacuolar 
ROS, with the subsequent reduction of parasite survival. 
However, phagolysosome involvement was only structural; no 
alteration was found in the number of lysosomes that compose it or the 
pH, which means that there was no functional impairment. Besides, the 
results obtained with staining with Lysotracker network suggest a 
particular location of lysosomes towards one end of the infected 
macrophage treated with the combined therapy, an arrangement that 
may be promoting the elimination of the parasite. An increase in the 
lipid bodies also was observed in all treatments, suggesting the chemical 
pressure on the parasites at the intracellular level and in the axenic 
cultures. These types of structures have been described as a response to 
cellular stress in trypanosomatids after the use of different types of 
medicines (Rodrigues and de Souza, 2008). 
A previous study demonstrated activity on cysteine protease for 
hydrazone-type compounds (Desai et al., 2004), suggesting that it reacts 
with the thiol group of cysteine and causes the inhibitory action. We 
found that both compounds TC1 and TC2 inhibited protease activity in 
promastigotes of L. braziliensis. Surprisingly, a strong protease inhibitory 
activity was also observed with the mixture of triterpene saponin SS, in 
Fig. 8. Zymographic profiles on the protease activities. Enzymatic activities detectable in promastigote extracts after 24 h of reaction, Comassie stain. A. Protease 
activity of L. braziliensis treated. B. Protease activity of L. braziliensis treated and then exposed to 25 μM of Cysteine protease inhibitor Leupeptin. C. Histogram of cells 
infected with amastigotes released from cells exposed for 24 h to each of the treatments alone or in combination. D. Parasitic load measured as MFI average 
fluorescence index of cells infected with amastigotes previously exposed to treatments. 
Table 3 
Inhibition of the enzymatic activity of Catepsin B from L. braziliensis.  
Compound Time (minutes) 







































































Data show the % inhibition of the enzymatic activity of cathepsin B after 2 h of 
exposure to 50 μg/mL of each compound. 
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L. braziliensis. Although the antileishmanial activity of saponins has been 
documented, protease inhibition in Leishmania has been little explored. 
Most studies use saponins as adjuvants and not as an active ingredient, 
due to their surfactant properties, facilitating absorption processes. 
However, some saponins have been reported as metalloproteinase in-
hibitors in the human keratinocyte model (Oh et al., 2015). Some 
experimental background on the mode of action of saponins suggests an 
interaction with CPY51 and inhibition of ergosterol synthesis (Melo 
et al., 2016). It is also recognized that saponins have destabilizing effects 
on cell membranes, even causing red cell lysis (Santos et al., 1997). 
Despite this, in the present work there were no alterations in the 
membrane permeability on the amastigote stage or promastigotes of 
different species after exposure to the triterpene saponin mixture iso-
lated from S. saponaria. 
Proteases in Leishmania are of crucial importance since they are 
related to vital processes of the parasite such as invasion, survival within 
the macrophage and modulation of the immune response (Silva-Almeida 
et al., 2014). In this work, it was found that amastigotes released from 
infected macrophages exposed for 24 h to the compounds, lose the 
ability to infect macrophages in vitro and decrease their survival inside 
the macrophage, after 96 h of infection. This effect is consistent with the 
survival functions within the macrophage and the modulation of the 
immune response, which has been documented in general for peptidases 
in Leishmania (Machado et al., 2019). We also demonstrated the 
decrease in infectivity and post-treatment survival, that there was a 
subtle effect of TC1 chromane derived hydrazones on the cysteine pro-
teases of L. braziliensis. These enzymes that are expressed constitutively 
during the parasite’s life cycle is crucial for survival within the macro-
phage (Somanna et al., 2002; Gerbaba and Gedamu, 2013; Siqueir-
a-Neto et al., 2018) Cysteine proteases in protozoan parasites. PLoS Negl 
Trop Dis 12(8): e0006512.). This enzyme has been postulated as a 
therapeutic target and a vaccine candidate against Leishmania spp. More 
than three decades ago, findings in L. mexicana showed that parasites 
without this enzyme are unable to generate lesions in mice, which 
translates into a protective effect against infection (Alexander et al., 
1998). Moreover, this effect has been applied to other trypanosomatids 
such as T. brucei, since the use of RNAi against this enzyme prevents 
mortality in infected animals, without splenomegaly, parasitological 
blood healing and increased survival (Abdulla et al., 2008). 
In synthesis, both the chromane hydrazones and the saponin SS 
affect the mitochondrial functioning, the SS being a potent destabilizer 
of the membrane potential of this organelle, and caused a decrease in 
ATP levels. For both individual treatments and combinations no changes 
in the permeability of the cytoplasmic membrane were observed. 
Additionally, there is decompensation of the redox balance that can lead 
to the death of the parasite, an effect that is not immediate but gradual, 
consolidating a parasitostatic effect. At the ultrastructure level, 
chromane-derived hydrazones modify the appearance of phag-
olysosome, although both the pH and the number of lysosomes were 
biochemically not altered. Also, the compounds affect the infective ca-
pacity and the replication of amastigotes, by altering the functionality of 
proteases, enzymes that have been described as crucial for intracellular 
survival. 
All these results suggest that the 4% ointment formulation contain-
ing TC1 or TC2 combined with SS in a 1:1 ratio, chromane hydrazone: 
saponin, has the potential to become an alternative for the topical 
treatment of CL. These results serve as the basis for future clinical trials 
that validate its safety and efficacy. A preliminary observational study in 
canines with LC is shown that the formulation of TC2: SS allows the 
healing of lesions in different anatomical locations and with different 
evolution times. 
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